Neil Bodick
Keine laufenden Positionen mehr
Profil
Neil Bodick is the founder of Flexion Therapeutics, Inc. which was founded in 2007.
He held the title of Chief Scientific Officer from 2017 to 2020.
Dr. Bodick's former job was as the Chief Operating & Medical Officer at Lilly Research Laboratories from 2000 to 2007.
He was also an Assistant Professor at Perelman School of Medicine.
Dr. Bodick has a doctorate from The Trustees of Columbia University in The City of New York and Albert Einstein College of Medicine, Inc. He also has an undergraduate degree from Cornell University and an MBA from The Wharton School of the University of Pennsylvania.
Ehemalige bekannte Positionen von Neil Bodick
| Unternehmen | Position | Ende |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Founder | 03.01.2020 |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Chief Operating Officer | 01.01.2007 |
| Perelman School of Medicine | Corporate Officer/Principal | - |
Ausbildung von Neil Bodick
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Cornell University | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
